As of Jun 22
| +0.0154 / +3.70%|
The 2 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 3.50, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +711.31% increase from the last price of 0.43.
The current consensus among 2 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.